Published January 19, 2012
| Version v1
Patent
Open
METHODS AND COMPOSITIONS TO REDUCE LIVER DAMAGE ASSOCIATED WITH CONDITIONS OR THERAPIES THAT AFFECT THE IMMUNE SYSTEM
Contributors
Patent applicants:
Description
One side-effect arising from the use of antibodies against TNF receptor family members as therapeutics can be liver damage which precludes the completion of clinical trial. A novel LT-dependent pathway is described that mediates liver cell injury in several disease models.
Files
US20120014947.pdf
Files
(1.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:57d18318d8265b0ed109cc1a6eb06da2
|
1.0 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201113183617 A
- Patent application number
- US 2012/0014947 A1
- Other
- oai:uchicago.tind.io:9418
Dates
- Patent filed
-
2011-07-15